GMAInsuBalance®: from scientific rationale to a complete nutraceutical concept.
A demonstration of how nutritional research, product strategy, branding and AI tools can converge in the early development of a food supplement.
A polyphenol-led approach to metabolic balance.
InsuBalance® is a GMA Food Intelligence demonstration concept exploring cardiometabolic wellbeing and insulin sensitivity support. Its hypothetical formulation is built around SensuPrime™, a fictional polyphenol complex inspired by olive, pomegranate, blackcurrant, grape and artichoke.
The value of the case is not the product, which does not exist, but the process: reviewing literature, defining the territory, building and visualising a concept, and making limitations explicit before technical, clinical and regulatory assessment.
Build an evidence map before the concept.
AI can organise research by population, dose, duration, endpoints and limitations while preserving the source trail.
The data belong to the studies. Not to the concept.
The figures describe specific preparations, populations and protocols. They do not demonstrate efficacy for InsuBalance® or SensuPrime™ and are not commercial claims.
Change associated with 12 weeks of olive-leaf polyphenols versus placebo in de Bock et al.
Result observed in the same crossover trial involving 46 overweight middle-aged men.
Studies included in the 2017 meta-analysis of cardiometabolic effects of anthocyanins.
InsuBalance® and SensuPrime™ are fictional demonstration concepts. No clinical studies have been conducted on the product or ingredient shown.
What could your team build with AI?
Start from a real activity inside your company and identify the tools, sources, stages and controls needed to turn it into a concrete first workflow.
Tell us about your case →From news
to application.
Receive the editorial selection or request a free introductory conversation on using AI tools and automation in nutraceutical work.